BAKER BROS. ADVISORS LP
Director; Director, 10% Owner · 8 filings · Latest: Jun 9, 2026
ACADIA PHARMACEUTICALS INC
BeOne Medicines Ltd.
Denali Therapeutics Inc.
INCYTE CORP
Kiniksa Pharmaceuticals International, plc
Prelude Therapeutics Inc
TScan Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|
ONC | BAKER BROS. ADVISORS LP | Director | May 22, 2026 | Sale | $23.82 | 10,998 | $262.0K | 142,570 | |
INCY | BAKER BROS. ADVISORS LP | Director, 10% Owner | May 8, 2026 | Option Exercise | $84.53 | 30,000 | $2.5M | 28,203,718 | |